Caparello, C. et al. 2012. Fixed-Dose Rate Gemcitabine Plus Capecitabine as Second-Line Treatment for Metastatic Pancreatic Cancer Patients Pretreated with Oxaliplatin. JOP. Journal of the Pancreas. 13, 5S (Sep. 2012), 596. DOI:https://doi.org/10.6092/1590-8577/1070.